These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38647377)

  • 1. DROSHA Regulates Mesenchymal Gene Expression in Wilms Tumor.
    Tiburcio PDB; Desai K; Kim J; Zhou Q; Guo L; Xiao X; Zhou L; Yuksel A; Catchpoole DR; Amatruda JF; Xu L; Chen KS
    Mol Cancer Res; 2024 Aug; 22(8):711-720. PubMed ID: 38647377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss or oncogenic mutation of DROSHA impairs kidney development and function, but is not sufficient for Wilms tumor formation.
    Kruber P; Angay O; Winkler A; Bösl MR; Kneitz S; Heinze KG; Gessler M
    Int J Cancer; 2019 Mar; 144(6):1391-1400. PubMed ID: 30367465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WILMS TUMOR MUTATIONAL SUBCLASSES CONVERGE TO DRIVE
    Xu L; Desai K; Kim J; Zhou Q; Guo L; Xiao X; Zhang Y; Zhou L; Yuksel A; Catchpoole DR; Amatruda JF; Chen KS
    medRxiv; 2023 Feb; ():. PubMed ID: 36778325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours.
    Rakheja D; Chen KS; Liu Y; Shukla AA; Schmid V; Chang TC; Khokhar S; Wickiser JE; Karandikar NJ; Malter JS; Mendell JT; Amatruda JF
    Nat Commun; 2014 Sep; 2():4802. PubMed ID: 25190313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors.
    Wegert J; Ishaque N; Vardapour R; Geörg C; Gu Z; Bieg M; Ziegler B; Bausenwein S; Nourkami N; Ludwig N; Keller A; Grimm C; Kneitz S; Williams RD; Chagtai T; Pritchard-Jones K; van Sluis P; Volckmann R; Koster J; Versteeg R; Acha T; O'Sullivan MJ; Bode PK; Niggli F; Tytgat GA; van Tinteren H; van den Heuvel-Eibrink MM; Meese E; Vokuhl C; Leuschner I; Graf N; Eils R; Pfister SM; Kool M; Gessler M
    Cancer Cell; 2015 Feb; 27(2):298-311. PubMed ID: 25670083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour.
    Torrezan GT; Ferreira EN; Nakahata AM; Barros BD; Castro MT; Correa BR; Krepischi AC; Olivieri EH; Cunha IW; Tabori U; Grundy PE; Costa CM; de Camargo B; Galante PA; Carraro DM
    Nat Commun; 2014 Jun; 5():4039. PubMed ID: 24909261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors.
    Walz AL; Ooms A; Gadd S; Gerhard DS; Smith MA; Guidry Auvil JM; Meerzaman D; Chen QR; Hsu CH; Yan C; Nguyen C; Hu Y; Bowlby R; Brooks D; Ma Y; Mungall AJ; Moore RA; Schein J; Marra MA; Huff V; Dome JS; Chi YY; Mullighan CG; Ma J; Wheeler DA; Hampton OA; Jafari N; Ross N; Gastier-Foster JM; Perlman EJ
    Cancer Cell; 2015 Feb; 27(2):286-97. PubMed ID: 25670082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA CRNDE promotes the development of Wilms' tumor by regulating microRNA-424.
    Cui WW; Sun YL; Chen C; Feng RR; Xu W; Meng JJ; Zhang K
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1088-1097. PubMed ID: 32096178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
    Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
    Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrences.
    Spreafico F; Ciceri S; Gamba B; Torri F; Terenziani M; Collini P; Macciardi F; Radice P; Perotti D
    Oncotarget; 2016 Feb; 7(8):8908-15. PubMed ID: 26802027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in microRNA processing genes in Wilms tumors derepress the
    Chen KS; Stroup EK; Budhipramono A; Rakheja D; Nichols-Vinueza D; Xu L; Stuart SH; Shukla AA; Fraire C; Mendell JT; Amatruda JF
    Genes Dev; 2018 Aug; 32(15-16):996-1007. PubMed ID: 30026293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network.
    Aiden AP; Rivera MN; Rheinbay E; Ku M; Coffman EJ; Truong TT; Vargas SO; Lander ES; Haber DA; Bernstein BE
    Cell Stem Cell; 2010 Jun; 6(6):591-602. PubMed ID: 20569696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wilms Tumor Suppressor, WT1, Cooperates with MicroRNA-26a and MicroRNA-101 to Suppress Translation of the Polycomb Protein, EZH2, in Mesenchymal Stem Cells.
    Akpa MM; Iglesias D; Chu L; Thiébaut A; Jentoft I; Hammond L; Torban E; Goodyer PR
    J Biol Chem; 2016 Feb; 291(8):3785-95. PubMed ID: 26655220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of Wilms tumor: from WT1 and microRNA to animal models.
    Tian F; Yourek G; Shi X; Yang Y
    Biochim Biophys Acta; 2014 Aug; 1846(1):180-7. PubMed ID: 25018051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG6 Promotes Wilms' Tumor Progression Through Regulating miR-429/FRS2 Axis.
    Wang Y; Liu J; Yao Q; Wang Y; Liu Z; Zhang L
    Cancer Biother Radiopharm; 2024 May; 39(4):264-275. PubMed ID: 33481659
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation.
    Huang L; Mokkapati S; Hu Q; Ruteshouser EC; Hicks MJ; Huff V
    Neoplasia; 2016 Feb; 18(2):71-81. PubMed ID: 26936393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAX3 is expressed in the stromal compartment of the developing kidney and in Wilms tumors with myogenic phenotype.
    Hueber PA; Fukuzawa R; Elkares R; Chu L; Blumentkrantz M; He SJ; Anaka MR; Reeve AE; Eccles M; Jabado N; Iglesias DM; Goodyer PR
    Pediatr Dev Pathol; 2009; 12(5):347-54. PubMed ID: 18666806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA LINC01339 Hinders the Development of Wilms' Tumor via MiR-135b-3p/ADH1C Axis.
    Yu Y; Liu Y
    Horm Metab Res; 2024 Mar; 56(3):244-254. PubMed ID: 37890508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CITED1 confers stemness to Wilms tumor and enhances tumorigenic responses when enriched in the nucleus.
    Murphy AJ; Pierce J; de Caestecker C; Ayers GD; Zhao A; Krebs JR; Saito-Diaz VK; Lee E; Perantoni AO; de Caestecker MP; Lovvorn HN
    Oncotarget; 2014 Jan; 5(2):386-402. PubMed ID: 24481423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of miR-204 and mir-483 5p expression with clinicopathological features of Wilms tumor: Could this provide foresight?
    Orgen Calli A; Issin G; Yilmaz I; Ince D; Tural E; Guzelis I; Cecen RE; Olgun HN; Gokcay D; Ozer E
    Jpn J Clin Oncol; 2023 Dec; 53(12):1170-1176. PubMed ID: 37647636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.